Porter Zikmund

Porter Zikmund has extensive experience in pharmaceutical sales, currently serving as a Senior Therapeutic Area Specialist at Bristol Myers Squibb since August 2024. Prior to this role, Porter Zikmund was a Neuroscience Sales Specialist at Intra-Cellular Therapies from February 2020, with previous positions including ADHD Sales Specialist at Ironshore Pharmaceuticals/IQVIA, CNS Specialty Account Manager at Lundbeck, and Metabolic Sales Specialist at Eisai/Endo Pharma. Notable achievements include launching and promoting several high-profile products such as Trintellix, Rexulti, and Vascepa across multiple therapeutic areas including psychiatry, cardiology, and neurology. Porter Zikmund's career began as a Professional Sales Representative at Somaxon Pharmaceuticals, building a strong foundation in sales and product launches. Education includes a B.S. in Business Administration from the University of South Florida and additional studies at the University of Iowa.